Acquisition Growth Conventus has expanded its product portfolio through acquisitions (Flower Orthopedics and IntraFuse assets), broadening its fracture repair and minimally invasive implant offerings. This creates cross-sell opportunities to new and existing customers and accelerates access to hospital systems and trauma centers. BD action: map overlapping surgeon networks and introduce bundled Cage implants with intramedullary components to win multi-line contracts.

Surgeon Value Cage technology is positioned to improve patient outcomes and surgeon experience while delivering economic value to stakeholders. Sales opportunities include emphasizing clinical differentiation, surgeon training programs, and KOL partnerships to drive adoption in trauma, orthopedic extremity programs, and outpatient settings; develop value dossiers focused on outcomes, OR efficiency, and total cost of care.

Funding Momentum Recent financing and leadership hires indicate readiness to scale manufacturing and go-to-market efforts. This supports pursuit of enterprise-wide hospital contracts, scalable distribution, and targeted marketing investments. BD actions: prepare pricing models, volume-based terms, and phased rollouts to regional hospital systems and ambulatory surgery centers.

MIS Demand Growing demand for minimally invasive fracture repair and extremity implants aligns with Conventus' intrafuse legacy and Cage platform. Target buyers include surgeons who perform MIS procedures, distributors serving trauma centers and ASCs, and GPOs. Action: develop clinical case studies and pilot programs to demonstrate value in MIS workflows.

Regional Strategy With a lean team based in Minnesota, Conventus can leverage the Midwest medical device ecosystem through regional distributors and partnerships with hospital networks and academic centers. Focus on early pilots and adopters in the region to validate the business model before broader national expansion.